ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32025-100mg |
|
1232861-58-3 |
Gemilukast (ONO-6950)
|
0 | C36H37F2NO5 | |
GC32025-50mg |
|
1232861-58-3 |
Gemilukast (ONO-6950)
|
0 | C36H37F2NO5 | |
GC32025-25mg |
|
1232861-58-3 |
Gemilukast (ONO-6950)
|
0 | C36H37F2NO5 | |
GC32025-10mg |
|
1232861-58-3 |
Gemilukast (ONO-6950)
|
0 | C36H37F2NO5 | |
GC32025-5mg |
|
1232861-58-3 |
Gemilukast (ONO-6950)
|
0 | C36H37F2NO5 | |
GC32024-20mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 | C25H36ClN3O3 | |
GC32024-10mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 | C25H36ClN3O3 | |
GC32024-5mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 | C25H36ClN3O3 | |
GC32024-1mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 | C25H36ClN3O3 | |
GC32023-10mg |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 | C14H21N5O2S | |
GC32023-5mg |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 | C14H21N5O2S | |
GC32023-10mM(1mLinDMSO) |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 | C14H21N5O2S | |
GC32022-20mg |
|
87549-36-8 |
Parcetasal (MR-897)
|
0 | C17H15NO5 | |
GC32022-10mg |
|
87549-36-8 |
Parcetasal (MR-897)
|
0 | C17H15NO5 | |
GC32022-5mg |
|
87549-36-8 |
Parcetasal (MR-897)
|
0 | C17H15NO5 | |
GC32022-1mg |
|
87549-36-8 |
Parcetasal (MR-897)
|
0 | C17H15NO5 | |
GC32021-20mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 | C10H11ClN2O2 | |
GC32021-10mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 | C10H11ClN2O2 | |
GC32021-5mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 | C10H11ClN2O2 | |
GC32021-1mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 | C10H11ClN2O2 | |